AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Based on the 15-minute chart of Avidity Biosciences, the Bollinger Bands have been expanding downward, indicating a bearish trend. The recent bearish Marubozu candlestick pattern at 08/25/2022 10:45 reinforces this notion, suggesting that sellers are currently driving the market. As a result, it is likely that the bearish momentum will continue.
Avidity Biosciences' Chief Medical Officer, Steven George Hughes, sold 2,208 shares of common stock on August 22, 2025, at a weighted-average price of $46.4047, totaling $102,461 [1]. This transaction, filed under SEC Form 4, indicates Hughes' direct ownership of 38,867 shares post-sale. The sale was conducted under a pre-established Rule 10b5-1 trading plan adopted on June 12, 2024.Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet